NCT00934752已完成1 期
An Exploratory Study Investigating the Use of the Lutonix Paclitaxel-Coated Balloon in Conjunction With Bare Metal Stenting in Patients With De Novo Coronary Lesions.
C. R. Bard3 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2009年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
- 试验地点
- 3
- 主要终点
- Mean percent stent volume obstruction as measured by optical coherence tomography (OCT)
研究概览
简要总结
The study will enroll patients with angiographically significant coronary de novo lesions. Subjects will be randomized 1:1 and treated with a Lutonix catheter either before or after bare-metal stenting (BMS). The purpose is to assess the feasibility, safety and efficacy of the Lutonix Catheter for treatment of de novo coronary artery stenosis using two distinct treatment strategies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or non-pregnant/non-breast feeding Female ≥ 18 years of age. Women of childbearing potential must have a negative pregnancy test (within 7 days of the procedure);
- •Documented stable angina pectoris Canadian Cardiovascular Society Classification (CCSC) 1-4, unstable angina pectoris with documented ischemia (Braunwald I-II) or documented silent ischemia;
- •Left ventricular ejection fraction (LVEF) ≥ 25%;
- •Patient is an acceptable candidate for PTCA, stenting, and emergent coronary artery bypass grafting (CABG);
- •Patient is willing to provide informed consent and comply with follow-up visits and testing schedule;
- •Target lesion is a de novo lesion in a native coronary artery vessel;
- •Initial stenosis is ≥ 50% and < 100% by visual estimate or quantitative coronary angiography (QCA);
- •Reference Vessel Diameter (RVD) is ≥ 2.5 and ≤ 3.25 prior to predilation;
- •Target lesion is ≤18mm in length and can be treated in its entirety by no more than 1 single Lutonix Catheter balloon and 1 single BMS;
- •Guidewire is able to cross lesion and be placed in distal vessel prior to enrollment;
- •Enrollment permitted after successful treatment of 1 non-study lesion in a single other non-study vessel (not in the same vascular territory as the study lesion). Successful treatment is defined as ≤ 30% residual stenosis with Thrombolysis in Myocardial Infarction (TIMI) Grade III flow and not evidence of dissection.
排除标准
- •History of stroke within past 6 months;
- •History of myocardial infarction (MI) or thrombolysis within 72 hours of randomization;
- •Prior vascular brachytherapy;
- •Uncontrollable allergies to procedure medications, materials or contrast;
- •Angiographic evidence of thrombus or dissection within the target vessel;
- •Intervention of another coronary lesion ≤ 60 days before index procedure day or planned following index procedure;
- •Target lesion is planned to be treated with something other than PTCA and stent (i.e., cutting-balloon, atherectomy, vascular brachytherapy (VBT), etc.);
- •Target lesion is in the Left Main and has excessive calcification or tortuosity or involves bifurcation disease of vessel ≥ 2.5mm;
- •Known sensitivity or has received paclitaxel or other antimitogenic agent within 12 months prior to target vessel treatment;
- •Patient has any previous intervention (PTCA, stent, etc.) of the target coronary vessel;
- •Any medical condition, in the investigators opinion, that should preclude the patient from the study or patient has a life expectancy less than 24 months;
- •Known creatine kinase-MB (CKMB) > 2x upper limit of normal (ULN) or positive Troponin;
- •Creatinine > 2.0 mg/dl;
- •Leukocyte < 3500/mL;
- •Platelet < 100,000 mL or > 750,000 mL;
- •Currently taking or must resume warfarin;
- •Patient is contraindicated for antiplatelet therapy or it will need to be withdrawn for a planned procedure;
- •The subject is currently participating in another investigational drug or device study.
结局指标
主要结局
Mean percent stent volume obstruction as measured by optical coherence tomography (OCT)
时间窗: 6 months
次要结局
- Minimal Lumen Area(6 Months)
- Stent Symmetry(6 Months)
- Stent Expansion(6 Months)
- Stent Malposition(6 Months)
研究者
研究点 (3)
Loading locations...
相似试验
已完成
不适用
Retrospective Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery DiseaseNon-Obstructive Coronary Artery DiseaseNCT03584321Merck KGaA, Darmstadt, Germany1,600
已完成
3 期
Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)Coronary DiseaseHypercholesterolemiaNCT00092599Organon and Co410
Unknown
不适用
The Promus Element Rewards StudyCoronary StenosisNCT01794065Medstar Health Research Institute500
已完成
不适用
Coronary CT Angiography in Aneurysms Repaired With Open or Endovascular ApproachComplex Aortic SurgeryNCT01211548The Cleveland Clinic40
已完成
不适用
Prospective International Study of Coronary Subtraction Using 320 Detector Row CT (CorSub)Coronary Artery DiseaseNCT02303067National Heart, Lung, and Blood Institute (NHLBI)13